SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Jun-24 2:29 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 18-Jun-24 | Grant | 5,345 | -- | -- | 27% 19.73K to 25.07K | |
04-Jun-24 4:42 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Jun-24 | Option Exercise | 4,000 | -- | -- | 50% 8.0K to 12.0K | |
09-Jun-23 2:29 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 07-Jun-23 | Grant | 3,860 | -- | -- | 24% 15.87K to 19.73K | |
19-Sep-22 5:08 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 16-Sep-22 | Grant | 8,000 | -- | -- | 100% 0 to 8.0K | |
28-Jun-22 1:48 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-22 | Grant | 3,300 | -- | -- | 26% 12.57K to 15.87K | |
23-Jul-21 4:48 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 21-Jul-21 | Disposition | 14,629 | -- | -- | (100%) 14.63K to 0 | |
28-Jun-21 6:25 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 24-Jun-21 | Grant | 2,145 | -- | -- | 21% 10.43K to 12.57K | |
24-May-21 4:27 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 20-May-21 | Grant | 2,495 | -- | -- | 21% 12.13K to 14.63K | |
30-Jun-20 1:10 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 26-Jun-20 | Grant | 2,550 | -- | -- | 32% 7.88K to 10.43K | |
18-May-20 5:10 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 14-May-20 | Grant | 4,409 | -- | -- | 57% 7.72K to 12.13K | |
13-Jun-19 4:38 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 11-Jun-19 | Grant | 3,000 | -- | -- | 62% 4.88K to 7.88K | |
17-May-19 4:34 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 15-May-19 | Grant | 3,466 | -- | -- | 81% 4.26K to 7.72K | |
20-Jun-18 6:16 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 19-Jun-18 | Grant | 3,000 | -- | -- | 160% 1.88K to 4.88K | |
11-May-18 4:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 09-May-18 | Grant | 2,174 | -- | -- | 104% 2.08K to 4.26K | |
08-Feb-18 7:15 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-18 | Grant | 2,085 | -- | -- | 100% 0 to 2.08K | |
22-Jun-17 7:20 PM View: | Ultragenyx Pharmaceutical I... (RARE) | 22-Jun-17 | Grant | 1,875 | -- | -- | 100% 0 to 1.88K | |
19-Mar-15 7:41 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Disposition | 43,041 | -- | -- | (100%) 43.04K to 0 | |
19-Mar-15 7:41 PM View: | Allergan Inc. (AGN) | 17-Mar-15 | Option Exercise | 8,860 | -- | -- | 26% 34.18K to 43.04K | |
09-Jan-15 5:30 PM View: | Allergan Inc. (AGN) | 30-Dec-14 | Gift | 3,780 | -- | -- | (10%) 37.96K to 34.18K | |
08-May-14 7:01 PM View: | Allergan Inc. (AGN) | 06-May-14 | Grant | 2,499 | -- | -- | 7% 35.46K to 37.96K | |
02-May-13 9:01 PM View: | Allergan Inc. (AGN) | 30-Apr-13 | Grant | 1,551 | -- | -- | 5% 33.91K to 35.46K | |
02-May-12 8:35 PM View: | Allergan Inc. (AGN) | 01-May-12 | Grant | 4,800 | -- | -- | 16% 29.11K to 33.91K | |
05-May-11 7:49 PM View: | Allergan Inc. (AGN) | 03-May-11 | Grant | 4,800 | -- | -- | 20% 24.3K to 29.1K | |
03-Nov-08 8:02 PM View: | Allergan Inc. (AGN) | 03-Nov-08 | Market Purchase | 300 | $39.35 | $11,803.70 | 1% 24.0K to 24.3K | 258% |
15-May-08 3:27 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 14-May-08 | Disposition | 688,957 | $25.00 | $17,223,900.00 | (100%) 688.96K to 0 | < 1% |
12-May-08 4:58 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 09-May-08 | Disposition (change in control) | 48,218 | $25.00 | $1,205,450.00 | (7%) 737.17K to 688.96K | < 1% |
08-May-08 9:04 PM View: | Allergan Inc. (AGN) | 06-May-08 | Grant | 14,400 | -- | -- | 150% 9.6K to 24.0K | |
28-Apr-08 4:34 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 24-Apr-08 | Gift | 68,899 | -- | -- | 9% 807.86K to 876.75K | |
28-Apr-08 4:34 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 24-Apr-08 | Gift | 68,899 | -- | -- | (8%) 876.75K to 807.86K | |
11-Mar-08 4:11 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 07-Mar-08 | Market Sale (Planned) | 14,096 | $13.34 | $188,036.00 | (2%) 825.39K to 811.29K | (87%) |
04-Mar-08 9:11 AM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 29-Feb-08 | Market Sale (Planned) | 23,820 | $13.67 | $325,660.00 | (3%) 849.21K to 825.39K | (82%) |
19-Feb-08 5:06 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 14-Feb-08 | Grant | 143,890 | -- | -- | 21% 701.88K to 845.77K | |
20-Jul-07 11:04 AM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 19-Jul-07 | Market Sale (Planned) | 33,664 | $10.61 | $357,175.00 | (5%) 734.68K to 701.01K | (135%) |
03-May-07 8:39 PM View: | Allergan Inc. (AGN) | 01-May-07 | Grant | 4,800 | -- | -- | 100% 0 to 4.8K | |
12-Mar-07 4:13 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 08-Mar-07 | Market Sale (Planned) | 10,771 | $10.41 | $112,126.00 | (1%) 745.45K to 734.68K | (140%) |
01-Mar-07 4:34 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 27-Feb-07 | Grant | 211,200 | -- | -- | 40% 534.25K to 745.45K | |
30-Oct-06 4:26 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 27-Oct-06 | Option Exercise | 112,500 | $9.77 | $1,099,500.00 | 21% 533.34K to 645.84K | |
30-Oct-06 4:26 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 27-Oct-06 | Market Option Sale (Planned) | 112,500 | $11.50 | $1,293,970.00 | (17%) 645.84K to 533.34K | (117%) |
08-Mar-06 3:58 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 06-Mar-06 | Grant | 133,335 | -- | -- | 33% 400.0K to 533.34K | |
20-Jul-05 12:39 PM View: | Millennium Pharmaceuticals ... (MLNMDD.PK) | 18-Jul-05 | Grant | 400,000 | -- | -- | 100% 0 to 400.0K |